Edward Boyer, MD, PhD, professor of emergency medicine, comments on the recall of an atomizer used to administer naloxone.
A new study by Jeremy Luban, MD, the David J. Freelander Professor in AIDS Research and professor of molecular medicine and biochemistry & molecular pharmacology, found that a mutation to the Ebola virus during the 2013-2016 West Africa outbreak made it easier for the virus to infect human cells.
An op-ed by Arlene Ash, PhD, professor of quantitative health sciences, explores the relevance and importance of conducting post-election audits of paper ballots.
Jennifer Wang, MD, associate professor of medicine, comments on an experimental way of treating influenza using nanoparticles.
Job Dekker, PhD, Howard Hughes Medical Institute Investigator, professor of biochemistry & molecular pharmacology and co-director of the Program in Systems Biology, explains how the genome is packed into our cells.
A study by Jonathan Kay, MD, professor of medicine, found that the 5-year safety data of 50-mg and 100-mg golimumab remained consistent with its 3-year results.
Susanne Muehlschlegel, MD, MPH, associate professor of neurology, has developed a new tool that may help predict a person’s chance of survival after a gunshot wound or other penetrating brain injury.
The groundbreaking work of Job Dekker, PhD, Howard Hughes Medical Institute Investigator, professor of biochemistry & molecular pharmacology and co-director of the Program in Systems Biology, to map the 3D shape of the genome is referenced in an article on the complexity of the human genome.
A story examining the complex interaction between different genes includes quotes from A.J. Marian Walhout, PhD, professor of molecular medicine and co-director of the Program in Systems Biology.
Kerstin Nündel, PhD, instructor in medicine, received a three-year, $574,000 grant from the Lupus Research Alliance to examine how the white blood cells called B cells go haywire in some individuals to cause the organ damage that is the hallmark of lupus.
The Horae Gene Therapy Center at UMMS, led by Guangping Gao, PhD, the Penelope Booth Rockwell Chair in Biomedical Research and professor of microbiology & physiological systems, will partner with Philadelphia-based Spark Therapeutics to figure out better ways to get disease-curing genes into cells.
An op-ed by Edward Boyer, MD, PhD, professor of emergency medicine, and Kavita Babu, MD, associate professor of emergency medicine, calls for the regulation of Kratom, an herb often used by chronic opioid users to curb cravings.
UMass Medical School is part of a multistate team researching how environment, lifestyle and genetics influence health. The project is part of the NIH Precision Medicine Initiative Cohort Program, which hopes to collect and analyze the personal health and lifestyle information, and biological samples, of as many as a million people over several years. The data will be used to develop prevention strategies and treatments that are based on a person’s own characteristics.
Sumner H. Burstein, PhD, professor emeritus, is referenced in a story about Corbus Pharmaceuticals for his discovery of the anti-inflammatory drug Resunab.
Lawrence M. Rhein, MD, professor of pediatrics, is quoted in a story about a new study which found that public-health efforts to encourage breast-feeding are increasingly coming into conflict with guidelines to ensure babies sleep safely.
The career and research of Robert H. Brown Jr., DPhil, MD, the Leo P. and Theresa M. LaChance Chair in Medical Research and chair and professor of neurology, is explored by Boston Globe columnist Thomas Farragher.
UMass Medical School sponsored the Geek Is Glam (GIG) STEM Expo at WPI that brought together more than 430 Girl Scouts from Central and Western Massachusetts to celebrate science, technology, engineering and mathematics.
Anastasia Khvorova, PhD, professor in the RNA Therapeutics Institute, talks about the therapeutic promise of RNAi and the strides made over the last decade to develop new drugs for clinical application.